Result update Q4, full year 2020 and the board of directors’ dividend proposal - Regulatory information

27-01-2021   Regulatory press release

Preliminary numbers indicate very strong growth for ADDvise Group during the fourth quarter for 2020, which will be substantially better than last year. ADDvise Group considers this to be above market expectations. With a more normalized market, an increase of ADDvise’s own products and margins, and a continued control of costs; EBITDA has increased as a result in the fourth quarter 2020. The net sales and EBITDA result 2020 will be ADDvise Group’s strongest so far.

  • The EBITDA result of the fourth quarter 2020 is estimated to approximately SEK 15.9 million (9.6), corresponding to an increase of 66.0 %.
  • The EBITDA margin of the fourth quarter 2020 is estimated to approximately 16.5 % (9.4).   
  • The EBITDA result of the full year 2020 is estimated to approximately SEK 45.9 million (30.7), corresponding to an increase of 49.6 %.
  • The EBITDA margin of the full year 2020 is estimated to approximately 12.8 % (8.8).
  • The net sales of the fourth quarter 2020 is estimated to approximately SEK 96.9 million (101.7), corresponding to a decrease of 4.7 %.
  • The net sales of the full year 2020 is estimated to approximately SEK 358.5 million (349.9), corresponding to an increase of 2.5 %.

In the light of ADDvise Group’s growth and strong cash flow during the full year 2020, the board of directors’ of ADDvise Group proposes a dividend of 0.02 SEK (0.0) per share for the financial year 2020.

All numbers in this press release are preliminary and unaudited. The final report for the fourth quarter of 2020 will be published on 25 February 2021.
 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se


Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 27 January 2021 at 17:20 CET.
 

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

           

Latest press releases

ADDvise completes the acquisition of MRC Systems FZE

Regulatory

ADDvise Group AB (publ) (”ADDvise”) has today completed the acquisition of all shares in MRC Systems FZE (”MRC”). The signing of the share purchase agreement has been communicated to the market via a press release on 16 February 2021. The total purchase price amounts to USD 8.00 million, of which USD 4.50 million has been…

ADDvise signs Letter of Intent to acquire Medisuite, LLC

Regulatory

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Medisuite, LLC (”Medisuite”) regarding an acquisition of 100 percent of the shares in Medisuite. Medisuite is an American online pharmacy that specializes in medication for men’s health. The prescription medication that is marketed by Medisuite is mainly used for treatment of…

ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds

Regulatory

ADDvise Group AB (publ) (“ADDvise") hereby announces that ADDvise’s up to SEK 240,000,000 senior unsecured callable floating rate bonds with ISIN SE0010298166 (the "Bonds"), will be redeemed in advance in accordance with Clause 8.3 (Voluntary total redemption (call option)) of the terms and conditions of the Bonds. The redemption date will be 18 June 2021.…